IL6 and congenital rubella syndrome: While CRS has been increasingly well-characterized and effectively managed with targeted interventions such as interleukin-6 (IL-6) blockade, ICANS remains less understood with respect to its pathophysiology, diagnostic criteria, and optimal treatment strategies.